EVMN
Evommune, Inc.
NYSE: EVMN · HEALTHCARE · BIOTECHNOLOGY
$23.80
-0.21% today
Updated 2026-04-30
Market cap
$914.15M
P/E ratio
—
P/S ratio
70.32x
EPS (TTM)
$-11.22
Dividend yield
—
52W range
$14 – $33
Volume
0.3M
Evommune, Inc. (EVMN) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
0 of 2
Last 2 quarters
Avg EPS surprise
-135.1%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
—
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-6.1%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-8.2%
2025-12-11
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-26 | $-1.43 | -70.2% | $23.13 | $22.18 | -4.1% |
| 2025-12-11 | $-8.07 | -908.8% | $19.61 | $18.01 | -8.2% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.84 | $-1.43 | -70.2% | — | — |
| 2025-09-30 | $-0.80 | $-8.07 | -908.8% | $10.00M | — |
Frequently asked questions
Has Evommune, Inc. beaten earnings estimates?
Evommune, Inc. has beaten Wall Street EPS estimates in 0 of its last 2 quarterly reports, with an average EPS surprise of -135.1% over the last 2 quarters.
How does EVMN stock react to earnings?
EVMN stock has moved an average of -6.1% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.